Management of Progressive Disease in Idiopathic Pulmonary Fibrosis

NCT03939520 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

279

Enrollment

OTHER

Sponsor class

Conditions

Progressive Idiopathic Pulmonary Fibrosis

Interventions

DRUG: pirfenidone and nintedanib
DRUG: pirfenidone or nintedanib
DRUG: pirfenidone or nintedanib

Sponsor

Hospices Civils de Lyon